Cambridge Cognition wins £1.0m contract with 'top ten' pharma company
Cambridge Cognition Holdings
28.33p
13:50 15/11/24
-0.58%
-0.17p
Software developer Cambridge Cognition has won a £1.0m contract as the cognitive assessment partner for a late phase cancer trial.
FTSE AIM All-Share
728.67
15:45 15/11/24
n/a
n/a
Health Care Equipment & Services
10,430.75
15:44 15/11/24
0.23%
23.76
Cambridge Cognition said on Friday that revenue from the contract, its second with a "top ten pharmaceutical company", was expected to be recognised over the next six years.
Chief executive Matthew Stork said: "This pharmaceutical client has a long-standing commitment to improving outcomes for cancer patients and we are delighted to be supporting their efforts.
"We expect that this could become a considerable growth area for Cambridge Cognition in the future."
As of 1030 BST, Cambridge Cognition shares were up 7.14% at 176.25p.